|Chemical Name||obeticholic acid|
|Dosage Form||Tablet (oral; 5 mg, 10 mg)|
|Drug Class||Receptor agonists|
|Company||Intercept Pharms Inc|
- For the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.